CMS Issues Addition Guidance on Emergency Preparedness Testing The Quality, Safety & Oversight (QSO) Group at the Centers for Medicare & Medicaid Services (CMS) has issued a revised QSO -20-41-All memo to provide additional guidance and clarifications on the emergency preparedness standard for testing requirements due to the ongoing...
Read moreBiosimilars: Interchangeable Products May Increase Patient Access Depending on state pharmacy laws, you may substitute an interchangeable biosimilar product at the pharmacy, much like substituting a generic for a brand-name drug. This helps increase patient access to biologics and may reduce patient costs. Learn more about Interchangeable Biological Products from the...
Read morePatient Eligibility Information for Additional Services — Now Available You can now check eligibility (PDF) for these Medicare-covered services: Flu shots provided in the last 18 months Pneumococcal shots (HCPCS codes 90671 and 90677; eligibility information is already available for 90670 and 90732) Cognitive Assessment & Care Plan Services (CPT 99483) Colorectal cancer screening —...
Read moreCOVID-19: New Codes for Moderna Vaccine Booster Doses On March 29, 2022, the FDA amended the Moderna COVID-19 vaccine emergency use authorization (PDF), including new packaging for vaccine boosters (blue cap). CMS issued new codes, effective March 29, 2022, for the vaccine booster and administration: Code: 91309 Long descriptor: Severe acute...
Read moreEligible Individuals Can Receive Second COVID-19 Booster Shot at No Cost On April 6, CMS announced it will pay for a second COVID-19 booster shot of either the Pfizer-BioNTech or Moderna COVID-19 vaccines without cost sharing, as it continues to provide coverage for this critical protection from the virus....
Read moreHealthCare Synergy Partners with nVoq to Improve Clinician Experience for Home Health and Hospice HealthCare Synergy selects nVoq to be their preferred speech recognition provider March 24, 2022 – HealthCare Synergy, a leader in home health software and automations, announces a co-marketing partnership with nVoq Incorporated. HealthCare Synergy will...
Read moreCOVID-19 Monoclonal Antibodies: Revised Emergency Use Authorization for EVUSHELD On February 24, the FDA revised the emergency use authorization for tixagevimab co-packaged with cilgavimab (EVUSHELD™) to change the initial dose for the authorized use as pre-exposure prophylaxis of COVID-19 in certain adults and pediatric patients. For more information about...
Read more